Alkyl Amines Q1 FY27 PAT jumps 91% YoY; top management re-designated
ALKYLAMINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250 and 5.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alkyl Amines Q1 FY27 (June 2026): Revenue from operations rose 30% YoY to Rs 528 cr; PAT nearly doubled to Rs 94.63 cr (up 91%) on sharp margin expansion. PBT stood at Rs 124.67 cr vs Rs 66.34 cr. Auditor issued an unmodified limited review report. Board re-designated Yogesh Kothari as Executive Chairman, elevated Kirat Patel and Suneet Kothari as Joint Managing Directors from Oct 1, 2026. Rakesh Goyal re-designated as Executive Director - Operations from April 2027. Commission to Non-Executive Directors capped at 1% of net profits for 5 years from FY28, subject to shareholder approval.
Strong Q1 with revenue up 30% and PAT nearly doubled reflects sharp margin expansion. Orderly top management succession signals continuity for growth.